Philips Joins Unlock Aid to Make USAID the Agency of the Future
WASHINGTON — Philips, a global leader in health technology joined Unlock Aid today, becoming the first multinational to join the fast-growing coalition of global innovators. Founded by a mix of veterans from USAID, the State Department, and the White House, as well as leading international development sector innovators, Unlock Aid is driving reforms to make global development agencies like USAID more innovative and results-oriented.
“USAID can become the agency of the future, leading the charge to incubate and scale the innovations we need to confront immense global challenges from pandemics to climate change,” said Unlock Aid executive director Walter Kerr.
“The world’s most innovative public and private sector players have untapped scientific and technological expertise needed to address humanity’s biggest challenges. As one of the world’s leading medical technology innovators, we are so excited to have Philips as an Unlock Aid partner in our campaign to bring more innovation to bear to achieve the Sustainable Development Goals by 2030.”
“At Philips, innovation is part of our DNA with over 100 years of experience and nearly $2 billion spent last year alone on R&D at four major innovation centers around the world, including Cambridge, MA,” said Kimberly Mingo, Government Leader for Philips North America. “With Philips and Unlock Aid, you can combine private sector support for foreign development that will help to improve lives, including those in underserved communities, while also supporting a shared mission to advance health equity and outcomes abroad and at home.”
About Unlock Aid
Unlock Aid is a global coalition of committed individuals and innovative organizations working to drive reforms at global development institutions needed to achieve the Sustainable Development Goals. Devex recently named Unlock Aid one of 22 global development organizations to watch in 2022.
For more information, please contact Walter Kerr at [email protected].
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people’s health and well-being, and enabling better outcomes across the health continuum – from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2021 sales of EUR 17.2 billion and employs approximately 78,000 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.
For more information, please contact:
Philips North America